Lifecore Biomedical Inc., a fully integrated contract development and manufacturing organization (CDMO), has been selected by Nirsum Laboratories Inc. to provide CDMO services focused on supporting Nirsum’s clinical development of its lead development candidate, NRS-033.   Under the agreement, planned activities include assessing and transferring technology for the fill and finish process associated with NRS-033. Lifecore’s unique expertise in the fill and finish of sterile injectable pharmace...